PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers

PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers

Metastatic breast cancer is still incurable so far; new specifically targeted and more effective therapies for triple-negative breast cancer (TNBC) are required in the clinic. In this study, our clinical data have established that basal and claudin-low subtypes of breast cancer (TNBC types) express...

Full description

Bibliographic Details
Main Authors: Chen, L., Yuan, Y., Kar, S., Kanchi, M., Arora, S., Kim, J., Koh, P., Yousef, E., Samy, R., Shanmugam, M., Tan, T., Shin, S., Arfuso, Frank, Shen, H., Yang, H., Goh, B., Park, J., Gaboury, L., Lobie, P., Sethi, Gautam, Lim, L., Kumar, Alan
Format: Journal Article
Published: American Association for Cancer Research 2017
Online Access:http://hdl.handle.net/20.500.11937/60223

Similar Items

Similar Items